Voice from the field: Roberto Arroba

Costa Rica
10 April 2017

Roberto Arroba is the National coordinator of immunization in Costa Rica, in charge of the secretariat of the NITAG and also a core group member of the Global NITAG Network (GNN).

AMP_HD_20160511-194-2.jpg

You attended the GNN meeting last year, what was the main take home message?
NITAGs should be a priority for countries. They are the ones driving national immunization policies. Not only should NITAG meetings be held on a regular basis but also tackle national priority topics.


You are part of the GNN core group, what is the priority for the network?
The core group needs to be established officially in order to meet, if not in person, at least virtually. 


What’s happening for the NITAG in Costa Rica at the moment?
We are currently finishing a cost-effectiveness study on HPV. Hopefully, it will be over by May 2017. If it is cost-effective, it will lead to the NITAG recommendation to introduce the vaccine in the country. Similarly, the rotavirus vaccine was recommended by the NITAG following a cost-effectiveness study and we are now waiting to get the funding to introduce it. We are also very busy with the implementation of a national computerized nominal immunization registry that was recommended by the NITAG 4 years ago. The Ministry of Health is now enforcing the advice. The nominal immunization registry will be piloted in the private sector first.

 

Related News & Events

  • Costa Rica

    Costa Rica introduces two new vaccines into the national immunization program

    16.10.2017

    October 2017 marks the introduction of the rotavirus and human papillomavirus (HPV) vaccines in Costa Rica’s immunization program. This decision results from the recommendations of the country National Immunization Technical Advisory Group (NITAG). Since 2001, Costa Rica’s NITAG, which is called Comisión Nacional de Vacunación y Epidemiología (National Commission on Vaccination and Epidemiology), is in charge of establishing and periodically updating the national immunization schedule as well as formulating overall policies and strategies for immunization. In order to issue the recommendations, the NITAG conducted cost-effectiveness studies that were then approved by its members.

    Read more
  • Costa Rica

    Agenda for ProVac Regional Workshop is Out

    17.03.2016

    The workshop aims to provide national public health experts with training on tools and methods to estimate the impact, costs and cost-effectiveness of vaccines in order to guide decision makers in developing evidence-based immunization policies. The workshop will feature case examples for meningococcal vaccination.

    Expected outcomes:

    1. Participants are empowered to promote evidence-based decision making at the national level for immunization policy formulation.
    2. Participants increase knowledge regarding the use of economic evaluations to inform evidence-based decision making.
    3. Participants have capacity to apply methods learned to conduct national level cost-effectiveness analyses with technical support from PAHO’s ProVac Initiative.
    4. Participants are equipped with new tools and approaches to inform national priority setting processes around vaccine policy development.
    Read more
  • Chile
    Functioning

    Chile's NITAG documents the results of the committee's evaluation

    02.07.2019

    In this article, we describe the structure, functioning and work processes of Chile’s NITAG (CAVEI) and assess its functionality, quality of work processes and outputs, and integration of the committee into the Ministry of Health policy process using the Assessment tool for National Immunization Technical Advisory Groups.

    Read more